BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2410390)

  • 21. Prognostic determinants in extrahepatic bile duct cancer.
    Kurosaki I; Tsukada K; Watanabe H; Hatakeyama K
    Hepatogastroenterology; 1998; 45(22):905-9. PubMed ID: 9755978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
    Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
    Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoplasm of the hepatic hilum: the role of resection.
    Gazzaniga GM; Filauro M; Bagarolo C; Ciferri E; Bondanza G
    Hepatogastroenterology; 1993 Jun; 40(3):244-8. PubMed ID: 7686876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical management of primary bile-duct carcinoma.
    Keith RG; Fisher MM; Rosen IE; Brow JR
    Can J Surg; 1984 Jan; 27(1):51-4. PubMed ID: 6205739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical resection of hilar bile duct carcinoma and predictors of survival.
    Todoroki T; Kawamoto T; Koike N; Takahashi H; Yoshida S; Kashiwagi H; Takada Y; Otsuka M; Fukao K
    Br J Surg; 2000 Mar; 87(3):306-13. PubMed ID: 10718799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of surgery for Klatskin tumors.
    Lillemoe KD
    Curr Opin Gen Surg; 1994; ():161-7. PubMed ID: 7583956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrahepatic bile duct carcinoma: a western experience with 118 consecutive patients.
    Doglietto GB; Alfieri S; Pacelli F; Mutignani M; Costamagna G; Carriero C; Di Giorgio A; Papa V
    Hepatogastroenterology; 2000; 47(32):349-54. PubMed ID: 10791187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
    Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases.
    Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary carcinoma of the extrahepatic bile duct: characteristic features and implications in surgical treatment.
    Okamoto A; Tsuruta K; Matsumoto G; Takahashi T; Kamisawa T; Egawa N; Funata N
    J Am Coll Surg; 2003 Mar; 196(3):394-401. PubMed ID: 12648691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hepatectomy in the treatment of hilar bile duct carcinoma.
    Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H
    Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of carcinoma of the extrahepatic bile ducts.
    Black K; Hanna SS; Langer B; Jirsch DW; Rider WD
    Can J Surg; 1978 Nov; 21(6):542-5. PubMed ID: 83901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sclerosing adenocarcinomas of the hepatic hilum].
    Zoppi S; Maritato F; Taviani M; Cariati A; Terrizzi A; Costanzo A; Pavero R; Barabino C; Maritato P; Lazzarino C; Conti F; Larghero G; Valleriani M; Alitta P; Cariati E
    G Chir; 1996 Apr; 17(4):155-7. PubMed ID: 8754550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile duct carcinoma: trends in treatment in the nineties.
    Reed DN; Vitale GC; Martin R; Bas H; Wieman TJ; Larson GM; Edwards M; McMasters K
    Am Surg; 2000 Aug; 66(8):711-4; discussion 714-5. PubMed ID: 10966023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.
    Langer JC; Langer B; Taylor BR; Zeldin R; Cummings B
    Surgery; 1985 Oct; 98(4):752-9. PubMed ID: 4049246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.